DISCLAIMER This information represents neither an offer to buy or sell any security nor, because it does not take into account the differing needs of individual clients, investment advice. Those seeking investment advice specific to their financial profiles and goals should contact their Oscar Gruss & Son Incorporated sales representative. Oscar Gruss & Son Incorporated believes this information to be reliable, but no representation is made as to accuracy or completeness. This information does not analyze every material fact concerning a company, industry, or security. Oscar Gruss & Son Incorporated assumes that this information will be read in conjunction with other publicly available data. Matters discussed here are subject to change without notice. There can be no assurance that reliance on the information contained here will produce profitable results. A security denominated in a foreign currency is subject to fluctuations in currency exchange rates, which may have an adverse effect on the value of the security upon the conversion into local currency of dividends, interest, or sales proceeds. The value of securities and depositary receipts of foreign issuers that are denominated in United States dollars are also influenced by fluctuations in currency exchange rates. © 2016 Oscar Gruss & Son Incorporated. All rights reserved.MON/BAYN GR - SYT/ChemChina has 6.6% gross spread but that deal risk was primarily CFIUS which has been received. DD/DOW is more of a merger of equals (followed by three spins) and has been trading as such - no real spread throughout the deal, though DD had pre-deal premium in it due to activists pushing to break up the company. Initial SYT deal spread was low-teens but moved to high-teens in a very short time.
MON deal looks like it is already going to be priced in high-teens, partly due to long closing time frame (end of 2017) combined with higher antitrust uncertainty due industry consolidation (and AGU/POT deal, while an ancillary industry, makes the reviews even more complicated). Downside at 16x P/E of 2017E $5.40 EPS is $86.40/share; a 1x multiple increase is $91.80/share.